-
Something wrong with this record ?
Pentamethinium salts as ligands for cancer: Sulfated polysaccharide co-receptors as possible therapeutic target
T. Bříza, J. Králová, S. Rimpelová, M. Havlík, R. Kaplánek, Z. Kejík, P. Martásek, I. Mikula, P. Džubák, M. Hajdúch, T. Ruml, V. Král,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Video-Audio Media
- MeSH
- Antineoplastic Agents chemical synthesis chemistry metabolism pharmacology MeSH
- Apoptosis drug effects MeSH
- Benzothiazoles chemical synthesis chemistry metabolism pharmacology MeSH
- CHO Cells MeSH
- Cricetulus MeSH
- Sulfuric Acid Esters metabolism MeSH
- Glycosaminoglycans metabolism MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Indoles chemical synthesis chemistry metabolism pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Structure MeSH
- Cell Line, Tumor MeSH
- Pyridinium Compounds chemical synthesis chemistry metabolism pharmacology MeSH
- Drug Design MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Video-Audio Media MeSH
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A series of pentamethinium salts with benzothiazolium and indolium side units comprising one or two positive charges were designed and synthesized to determine the relationships among the molecular structure, charge density, affinity to sulfated polysaccharides, and biological activity. Firstly, it was found that the affinity of the pentamethinium salts to sulfated polysaccharides correlated with their biological activity. Secondly, the side heteroaromates displayed a strong effect on the cytotoxicity and selectivity towards cancer cells. Finally, doubly charged pentamethinium salts possessing benzothiazolium side units exhibited remarkably high efficacy against a taxol-resistant cancer cell line.
1st Faculty of Medicine Charles University Prague Kateřinská 32 121 08 Prague 2 Czech Republic
Institute of Molecular and Translational Medicine Hněvotínská 5 779 00 Olomouc Czech Republic
University of Chemistry and Technology Prague Technická 5 166 28 Prague 6 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034988
- 003
- CZ-PrNML
- 005
- 20191011085339.0
- 007
- ta
- 008
- 191007s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2018.02.011 $2 doi
- 035 __
- $a (PubMed)30273836
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bříza, Tomáš $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic. Electronic address: tomas.briza@vscht.cz.
- 245 10
- $a Pentamethinium salts as ligands for cancer: Sulfated polysaccharide co-receptors as possible therapeutic target / $c T. Bříza, J. Králová, S. Rimpelová, M. Havlík, R. Kaplánek, Z. Kejík, P. Martásek, I. Mikula, P. Džubák, M. Hajdúch, T. Ruml, V. Král,
- 520 9_
- $a A series of pentamethinium salts with benzothiazolium and indolium side units comprising one or two positive charges were designed and synthesized to determine the relationships among the molecular structure, charge density, affinity to sulfated polysaccharides, and biological activity. Firstly, it was found that the affinity of the pentamethinium salts to sulfated polysaccharides correlated with their biological activity. Secondly, the side heteroaromates displayed a strong effect on the cytotoxicity and selectivity towards cancer cells. Finally, doubly charged pentamethinium salts possessing benzothiazolium side units exhibited remarkably high efficacy against a taxol-resistant cancer cell line.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antitumorózní látky $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a benzothiazoly $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D052160
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a glykosaminoglykany $x metabolismus $7 D006025
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a indoly $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D007211
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a pyridinové sloučeniny $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D011726
- 650 _2
- $a estery kyseliny sírové $x metabolismus $7 D013463
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a audiovizuální média $7 D059040
- 700 1_
- $a Králová, Jarmila $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Rimpelová, Silvie $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 700 1_
- $a Havlík, Martin $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
- 700 1_
- $a Kaplánek, Robert $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
- 700 1_
- $a Kejík, Zdeněk $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
- 700 1_
- $a Martásek, Pavel $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
- 700 1_
- $a Mikula, Ivan $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Hněvotínská 5, 779 00 Olomouc, Czech Republic.
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Hněvotínská 5, 779 00 Olomouc, Czech Republic.
- 700 1_
- $a Ruml, Tomáš $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic.
- 700 1_
- $a Král, Vladimír $u University of Chemistry and Technology, Prague, Technická 5, 166 28, Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic. Electronic address: vladimir.kral@vscht.cz.
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 82, č. - (2019), s. 74-85
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30273836 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191011085759 $b ABA008
- 999 __
- $a ok $b bmc $g 1451648 $s 1073538
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 82 $c - $d 74-85 $e 20180216 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20191007